documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,680 rows where document_type = "Other" and posted_year = 2007 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: posted_month, comment_end_date, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

agency_id 4

posted_year 1

  • 2007 · 1,680 ✖

document_type 1

  • Other · 1,680 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-P-0188-0001 FDA FDA-2007-P-0188 Acknowledgement Letter from FDA DDM to Beckloff Associates, Inc. Other Acknowledgement Letter/Receipt 2007-12-28T05:00:00Z 2007 12     2015-05-07T18:08:20Z   0 0 090000648042a763
FDA-2007-D-0257-0002 FDA FDA-2007-D-0257 See Document ID FDA-2007-D-0257-0004 Other   2007-12-28T00:00:00Z 2007 12     2008-05-21T20:21:19Z   0 1 090000648042b1c4
FDA-2007-P-0414-0005 FDA FDA-2007-P-0414 Minutes of Telecon Between FDA/CDER and Dr. Victor Yu and Cristina Chiou Other MT-Memorandum of Telephone Conversation 2007-12-27T05:00:00Z 2007 12     2008-04-04T00:38:15Z   0 0 090000648042da1a
FDA-2007-N-0445-0003 FDA FDA-2007-N-0445 Number not used Other   2007-12-26T05:00:00Z 2007 12     2025-08-14T22:07:10Z   0 1 090000648042ddf6
FDA-2007-N-0197-0002 FDA FDA-2007-N-0197 Agenda - Adolescent Over-the-Counter (OTC) Drug Product Use: A Public Workshop Other LST-List 2007-12-26T05:00:00Z 2007 12     2025-08-14T20:30:52Z   0 0 090000648042a934
FDA-2007-N-0445-0002 FDA FDA-2007-N-0445 Number Not Used Other   2007-12-26T05:00:00Z 2007 12     2025-08-14T22:05:39Z   0 1 090000648042ddf5
FDA-2007-N-0445-0004 FDA FDA-2007-N-0445 Number not used Other   2007-12-26T05:00:00Z 2007 12     2025-08-14T22:08:41Z   0 1 090000648042ddf7
FDA-2007-N-0438-0002 FDA FDA-2007-N-0438 Acknowledgment Letter from FDA DDM to Buchanan Ingersoll & Rooney PC Other Acknowledgement Letter/Receipt 2007-12-26T05:00:00Z 2007 12     2025-08-11T20:21:37Z   0 0 090000648042dd74
FDA-2006-V-0402-0005 FDA FDA-2006-V-0402 Lynne L. Rice Other VRA-Approval for Variance 2007-12-21T05:00:00Z 2007 12     2008-04-11T23:22:39Z   0 0 0900006480460c6c
FDA-2007-P-0235-0001 FDA FDA-2007-P-0235 Acknowledgment Letter from FDA CDER to Mutual Pharmaceutical Company, Inc. Other Acknowledgement Letter/Receipt 2007-12-21T05:00:00Z 2007 12     2015-09-29T13:12:16Z   0 0 090000648042b04d
FDA-2007-V-0252-0001 FDA FDA-2007-V-0252 Acknowledgement Letter to KRJ Music Work Other ACK-Acknowledgement Letter 2007-12-21T05:00:00Z 2007 12     2008-04-09T14:15:14Z   0 0 090000648042b160
FDA-2007-V-0356-0003 FDA FDA-2007-V-0356 Lynne L. Rice - Approval for Variance Other VRA-Approval for Variance 2007-12-20T05:00:00Z 2007 12     2008-04-09T16:14:25Z   0 0 090000648042ba0b
FDA-2007-A-0099-0002 FDA FDA-2007-A-0099 Letter from FDA CDER Interim Response to AstraZeneca Ropes and Gray LLP Other Letter(s) 2007-12-20T05:00:00Z 2007 12     2014-01-21T00:25:14Z   0 0 0900006480429d7a
FDA-2007-V-0426-0002 FDA FDA-2007-V-0426 Lynne L. Rice - Approval for Variance Other VRA-Approval for Variance 2007-12-20T05:00:00Z 2007 12     2008-04-09T18:31:27Z   0 0 090000648042dbe4
FDA-2007-P-0243-0001 FDA FDA-2007-P-0243 Acknowledgement Letter to Michael J. Dochniak Other ACK-Acknowledgement Letter 2007-12-20T05:00:00Z 2007 12     2008-07-22T22:56:16Z   0 0 090000648042b0be
FDA-2007-P-0184-0001 FDA FDA-2007-P-0184 Acknowledgement Letter to Judy Slome Cohain Other ACK-Acknowledgement Letter 2007-12-18T05:00:00Z 2007 12     2008-07-07T17:57:57Z   0 0 090000648042a728
FDA-2007-P-0110-0001 FDA FDA-2007-P-0110 FDA/DDM to Physicians Committee for Responsible Medicine (PCRM) Other ACK-Acknowledgement Letter 2007-12-18T05:00:00Z 2007 12     2008-04-04T00:37:11Z   0 0 0900006480429e5f
FDA-2006-P-0275-0006 FDA Refrain from Approval of Any Abbreviated New Drug Application (ANDA) for Metoprolol Succinate Extended Release100 mg & 200 mg Tablets Subsequent to ANDA 76-640 from K. V. Pharmaceuticals-CLOSED FDA-2006-P-0275 Citizen Petition Denial from FDA CDER to KV Pharmaceutical Co Other Denial of Petition 2007-12-17T05:00:00Z 2007 12     2024-12-05T14:53:49Z   0 0 090000648045829b
FDA-2007-P-0417-0001 FDA FDA-2007-P-0417 Acknowledgement Letter to Consumers Union Other ACK-Acknowledgement Letter 2007-12-17T05:00:00Z 2007 12     2013-05-15T19:58:29Z   0 0 090000648042da4d
FDA-2007-P-0122-0052 FDA FDA-2007-P-0122 FDA/CFSAN Interim Response to Compassion Over Killing & Penn Law Animal Law Project-University of Pennsylvania Law School - Letter Other LET-Letter 2007-12-17T05:00:00Z 2007 12     2008-11-26T05:47:43Z   0 0 090000648042a1cf
FDA-2005-P-0253-0019 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442e7
FDA-2005-P-0253-0006 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442da
FDA-2005-P-0253-0005 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442d9
FDA-2005-P-0253-0013 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442e1
FDA-2005-P-0253-0012 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442e0
FDA-2005-P-0253-0021 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442e9
FDA-2005-P-0253-0008 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442dc
FDA-2005-P-0253-0016 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442e4
FDA-2005-P-0253-0009 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:03Z   0 0 09000064804442dd
FDA-2005-P-0253-0010 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442de
FDA-2005-P-0253-0017 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442e5
FDA-2005-P-0253-0014 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442e2
FDA-2005-P-0253-0015 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442e3
FDA-2005-P-0253-0018 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442e6
FDA-2005-P-0253-0020 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442e8
FDA-2005-P-0253-0011 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:03Z   0 0 09000064804442df
FDA-2005-P-0253-0007 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442db
FDA-2005-P-0253-0022 FDA Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 J. Shuren, Assistant Commissioner for Policy Other PDN-Petition Denial 2007-12-13T05:00:00Z 2007 12     2008-04-12T00:09:02Z   0 0 09000064804442ea
FDA-2007-V-0421-0001 FDA FDA-2007-V-0421 Acknowledgement Letter to X- Laser L. L. C. Other ACK-Acknowledgement Letter 2007-12-12T05:00:00Z 2007 12     2008-04-09T18:12:29Z   0 0 090000648042daca
FDA-2007-V-0253-0001 FDA FDA-2007-V-0253 Acknowledgement Letter to X- Laser, L. L. C. Other ACK-Acknowledgement Letter 2007-12-12T05:00:00Z 2007 12     2008-04-09T14:30:16Z   0 0 090000648042b16e
FDA-2007-P-0288-0002 FDA FDA-2007-P-0288 FDA/CDRH to Clinical and Laboratory Standards Institute Other LET-Letter 2007-12-11T05:00:00Z 2007 12     2008-04-04T00:37:52Z   0 0 090000648042b4f1
FDA-2007-P-0187-0001 FDA FDA-2007-P-0187 FDA/DDM to Alston & Bird LLP Other ACK-Acknowledgement Letter 2007-12-11T05:00:00Z 2007 12     2008-04-04T00:37:35Z   0 0 090000648042a754
FDA-2007-P-0115-0002 FDA FDA-2007-P-0115 CDRH to Clinical and Laboratory Standards Institute Other LET-Letter 2007-12-11T05:00:00Z 2007 12     2008-04-04T00:37:13Z   0 0 0900006480429ef7
FDA-2007-P-0187-0002 FDA FDA-2007-P-0187 FDA/DDM to Alston & Bird LLP Other ACK-Acknowledgement Letter 2007-12-11T05:00:00Z 2007 12     2008-04-04T00:37:35Z   0 0 090000648042a759
USDA-2007-0001-0002 USDA Semiannual Regulatory Agenda - Fall 2007 USDA-2007-0001 Regulatory Plan - Fall 2007 Other NA 2007-12-10T14:46:29Z 2007 12     2007-12-10T16:47:08Z   0 0 0900006480375b95
USDA-2007-0001-0001 USDA Semiannual Regulatory Agenda - Fall 2007 USDA-2007-0001 Semiannual Regulatory Agenda - Fall 2007 Other NA 2007-12-10T14:46:14Z 2007 12     2007-12-10T16:46:40Z   0 0 0900006480375b94
EPA-HQ-OA-2007-1172-0001 EPA Semiannual Regulatory Agenda - Fall 2007 EPA-HQ-OA-2007-1172 Semiannual Regulatory Agenda - Fall 2007 Other Significant Guidance 2007-12-10T14:42:07Z 2007 12     2010-07-15T19:23:55Z   0 0 0900006480375b20
FDA-2007-P-0066-0001 FDA FDA-2007-P-0066 FDA/ DDM to William L. Driscoll Other ACK-Acknowledgement Letter 2007-12-07T05:00:00Z 2007 12     2008-04-04T00:37:08Z   0 0 09000064804297f2
FDA-2007-E-0281-0005 FDA FDA-2007-E-0281 FDA/CDER to the USPTO - Letter Other LET-Letter 2007-12-06T05:00:00Z 2007 12     2026-01-06T23:23:28Z   0 0 090000648042b44b
FDA-2007-P-0245-0003 FDA FDA-2007-P-0245 FDA/CDER Interim Response to Perdue Pharma L.P. - Letter Other LET-Letter 2007-12-06T05:00:00Z 2007 12     2009-03-28T18:18:01Z   0 0 090000648042b0f0
FDA-2007-E-0106-0007 FDA FDA-2007-E-0106 USPTO to Intervet Inc. - Letter Other LET-Letter 2007-12-05T05:00:00Z 2007 12     2008-05-02T15:45:09Z   0 0 0900006480429e1e
FDA-2007-P-0234-0001 FDA FDA-2007-P-0234 Acknowledgement Letter to Terence J. Mix, Esq. Other ACK-Acknowledgement Letter 2007-12-04T05:00:00Z 2007 12     2012-09-22T20:26:02Z   0 0 090000648042b03f
FDA-2007-P-0182-0002 FDA FDA-2007-P-0182 FDA Center for Drug and Evaluation Research Response to Sanofi Aventis - Letter Other LET-Letter 2007-12-04T05:00:00Z 2007 12     2008-07-15T23:43:46Z   0 0 090000648042a706
EPA-R09-OAR-2007-1103-0003 EPA EPA-R09-OAR-2007-1103 Proposed Part 71 Permit for Salt River Landfill Other   2007-12-03T05:00:00Z 2007 12 2007-12-03T05:00:00Z 2008-01-08T04:59:59Z 2008-01-08T21:22:03Z   0 0 090000648036e43d
FDA-2007-H-0094-0003 FDA FDA-2007-H-0094 FDA Division of Dockets Management - Certificate of Service [FDA-2007-H-0094-0018] Other CS-Certificate of Service 2007-12-03T05:00:00Z 2007 12     2026-01-06T23:41:59Z   0 0 0900006480429d34
FDA-2007-H-0094-0002 FDA FDA-2007-H-0094 FDA/Administrative Law Judge - Order [FDA-2007-H-0094-0017] Other OR-Order 2007-12-03T05:00:00Z 2007 12     2026-01-06T23:40:08Z   0 0 0900006480429d33
FDA-2020-D-1925-0001 FDA FDA-2020-D-1925 Guidance for Industry: Preparation of Premarket Submissions for Food Contact Substances (Chemistry Recommendations) Other Guidance 2007-12-01T05:00:00Z 2007 12 2020-09-17T04:00:00Z   2024-11-12T23:24:55Z   1 0 090000648486323c
EPA-R09-OAR-2007-0985-0012 EPA EPA-R09-OAR-2007-0985 Cover Letter to Revised Proposed Permit Other   2007-11-30T05:00:00Z 2007 11 2007-11-30T05:00:00Z   2008-01-08T21:16:05Z   0 0 090000648036b119
EPA-R09-OAR-2007-0985-0014 EPA EPA-R09-OAR-2007-0985 November 30, 2007 Revised Statement of Basis and Ambient Air Quality Impact Report Other   2007-11-30T05:00:00Z 2007 11 2007-11-30T05:00:00Z   2008-01-08T21:20:17Z   0 0 090000648036b17f
FDA-2006-P-0006-0005 FDA To permit an ANDA Suitability for Eloxatin (Oxaliplatin for injection) FDA-2006-P-0006 Letter from FDA CDER to AAC Consulting Group/Kendle Other Letter(s) 2007-11-30T05:00:00Z 2007 11     2024-11-14T14:39:25Z   0 0 0900006480441445
FDA-2007-P-0123-0001 FDA FDA-2007-P-0123 Acknowledgement Letter to United Research Laboratories, Inc., Mutual Pharmaceutical Company, Inc. Other ACK-Acknowledgement Letter 2007-11-30T05:00:00Z 2007 11     2008-10-01T15:30:49Z   0 0 090000648042a1d7
FDA-2005-D-0445-0008 FDA Class II Special Controls: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle, re FDA-2012-N-0115 FDA-2005-D-0445 Guidance for Industry and Food and Drug Administration Staff: Class II Special Controls Guidance Document: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle; Final Guidance Document Other Guidance 2007-11-30T05:00:00Z 2007 11     2015-01-21T00:13:53Z   0 0 09000064804505f2
FDA-2006-P-0069-0005 FDA ANDA for ELOXATIN (oxaliplatin for injection) lyophilized powder for infusion, 50 mg and 100 mg vials FDA-2006-P-0069 Letter from FDA CDER to Frommer, Lawrence & Haug LLP Other Letter(s) 2007-11-30T05:00:00Z 2007 11     2024-11-13T14:54:20Z   0 0 0900006480444465
FDA-2007-P-0247-0006 FDA FDA-2007-P-0247 Letter from FDA CDER to Regulus Pharmaceutical Consulting, Inc Other Letter(s) 2007-11-30T05:00:00Z 2007 11     2025-03-04T22:09:52Z   0 0 090000648042b114
FDA-2006-P-0201-0005 FDA Determine whether Eloxatin (Oxaliplatin for Injection) 50 mg and 100 mg sterile lyophilized powder vials (NDA #21-492 has been withdrawn for safety or effectiveness reasons FDA-2006-P-0201 Elizabeth Sadove - FDA/CDER Final Response Other LET-Letter 2007-11-30T05:00:00Z 2007 11     2008-06-19T19:56:35Z   0 0 0900006480450f53
FDA-2006-P-0085-0005 FDA Determine whether Eloxatin (Oxaliplatin for Injection) has been voluntarily withdrawn or withheld from sale for safety or efficacy reasons FDA-2006-P-0085 Letter from FDA CDER to Sicor Pharmaceuticals, Inc. Other Letter(s) 2007-11-30T05:00:00Z 2007 11     2024-11-04T19:39:47Z   0 0 090000648044498d
FDA-2007-P-0410-0001 FDA FDA-2007-P-0410 FDA/DDM to Medicure Pharma, Inc. - Acknowledgement Letter Other ACK-Acknowledgement Letter 2007-11-30T05:00:00Z 2007 11     2009-03-31T13:27:52Z   0 0 090000648042d9a6
FDA-2005-D-0227-0019 FDA Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004; Guidance (Edition 2) FDA-2005-D-0227 FDA/CFSAN Response to Olga Nichols - Answer Other Answer 2007-11-29T05:00:00Z 2007 11     2012-03-14T01:00:38Z   0 0 09000064804420a7
FDA-2007-P-0403-0003 FDA FDA-2007-P-0403 Petition Approval from FDA CVM to Norbrook Inc Other Letter(s) 2007-11-28T00:00:00Z 2007 11     2025-05-09T00:32:49Z   0 0 090000648042d905
FDA-2005-D-0227-0018 FDA Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004; Guidance (Edition 2) FDA-2005-D-0227 FDA/CFSAN Response to Taro Dream Inc. (Pamela Day) - Answer Other Answer 2007-11-27T05:00:00Z 2007 11     2012-03-14T00:52:52Z   0 0 09000064804420a4
FDA-2007-P-0005-0003 FDA FDA-2007-P-0005 Interim Response Letter from FDA CDRH to Association of Medical Device Reprocessors Other Letter(s) 2007-11-27T00:00:00Z 2007 11     2025-05-08T19:39:46Z   0 0 0900006480429280
FDA-2007-P-0109-0001 FDA FDA-2007-P-0109 Acknowledgement Letter to Mandatory Alternatives Petition Coalition Other ACK-Acknowledgement Letter 2007-11-26T05:00:00Z 2007 11     2008-05-09T21:44:06Z   0 0 0900006480429e51
FDA-2007-D-0132-0002 FDA FDA-2007-D-0132 Guidance Other GDL-Guidance 2007-11-23T05:00:00Z 2007 11     2019-08-20T18:59:46Z   0 0 090000648042a2b9
FDA-2006-P-0205-0004 FDA Health Claim Petition: Barley Betafiber and Coronary Heart Disease FDA-2006-P-0205 FDA/CFSAN Request to Dockets Management - Letter Other LET-Letter 2007-11-23T05:00:00Z 2007 11     2009-01-23T21:32:10Z   0 0 090000648045139b
FDA-1999-D-0048-0007 FDA Impurities in New Veterinary Medicinal Products; International Cooperation on Harmonisation of Technical Requirements, VICH GL11 FDA-1999-D-0048 Guidance for Industry Impurities in New Veterinary Medicinal Products (Revised) VICH GL11 (R) Revised Final Guidance Other Guidance 2007-11-23T05:00:00Z 2007 11     2025-06-10T18:44:15Z   0 0 09000064804a600a
FDA-2007-E-0461-0002 FDA FDA-2007-E-0461 FDA/CDER to U.S. Patent and Trademark Office Other LET-Letter 2007-11-21T05:00:00Z 2007 11     2008-04-04T00:35:05Z   0 0 090000648042df85
FDA-2007-E-0282-0002 FDA FDA-2007-E-0282 FDA/CDER to USPTO - Letter Other LET-Letter 2007-11-21T05:00:00Z 2007 11     2008-12-05T18:44:49Z   0 0 090000648042b460
FDA-2006-D-0299-0005 FDA Stability Testing of New Veterinary Drug Substances and Medicinal Products (Revision) VICH GL3 (R) (#73) FDA-2006-D-0299 CVM GFI #73 (VICH GL3(R)) Stability Testing of New Veterinary Drug Substances Other Guidance 2007-11-21T05:00:00Z 2007 11 2007-11-21T05:00:00Z   2024-11-07T21:52:21Z   1 0 0900006480458fb9
FDA-2007-E-0165-0002 FDA FDA-2007-E-0165 Letter from FDA/CDER to USPTO Other LET-Letter 2007-11-21T05:00:00Z 2007 11     2026-01-06T01:03:51Z   0 0 090000648042a511
EPA-HQ-OPP-2007-0725-0001 EPA EPA-HQ-OPP-2007-0725 Special Docket: Acetochlor Registration Agreement and Monitoring Program Other NA 2007-11-20T05:00:00Z 2007 11 2007-11-20T05:00:00Z   2009-05-18T12:11:58Z   0 0 09000064803664e8
FDA-2005-D-0227-0017 FDA Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004; Guidance (Edition 2) FDA-2005-D-0227 FDA/CFSAN Response to Su Alai - Answer Other Answer 2007-11-20T05:00:00Z 2007 11     2012-03-14T00:44:08Z   0 0 09000064804420a2
FDA-2004-P-0338-0005 FDA Refrain From Approving Any ANDA Submitted Under Section 505(j) of the FDCA for A Generic Version of Efudex Cream-CLOSED FDA-2004-P-0338 Ted Sherwood Other MM-Memorandum of Meeting 2007-11-20T05:00:00Z 2007 11     2008-04-12T00:49:25Z   0 0 0900006480473328
FDA-2007-N-0198-0004 FDA FDA-2007-N-0198 FDA/CFSAN/ONLDS Other M-Memorandum 2007-11-20T05:00:00Z 2007 11     2008-04-04T00:35:55Z   0 0 090000648042a9d3
FDA-2007-N-0198-0005 FDA FDA-2007-N-0198 FDA/CFSAN/ONLDS Other TR-Transcript 2007-11-20T05:00:00Z 2007 11     2008-04-04T00:35:55Z   0 0 090000648042a9d4
FDA-2007-N-0198-0003 FDA FDA-2007-N-0198 FDA/CFSAN/ONLDS Other M-Memorandum 2007-11-20T05:00:00Z 2007 11     2008-04-04T00:35:55Z   0 0 090000648042a9d2
FDA-2007-P-0416-0001 FDA FDA-2007-P-0416 Acknowledgement Letter from FDA DDM to Sapna Lohiya (Royal Medical Group) Other Acknowledgement Letter/Receipt 2007-11-20T05:00:00Z 2007 11     2016-03-10T16:24:35Z   0 0 090000648042da3a
FDA-2007-N-0198-0006 FDA FDA-2007-N-0198 FDA/CFSAN/ONLDS Other TR-Transcript 2007-11-20T05:00:00Z 2007 11     2008-04-04T00:35:55Z   0 0 090000648042a9d5
FDA-2007-P-0064-0002 FDA FDA-2007-P-0064 FDA/CDER to Center for Dermatology and Laser Surgery Other LET-Letter 2007-11-20T05:00:00Z 2007 11     2008-04-04T00:37:07Z   0 0 09000064804297ca
FDA-2007-P-0051-0001 FDA FDA-2007-P-0051 Acknowledgement Letter to Sidelines National Support Network Other ACK-Acknowledgement Letter 2007-11-19T05:00:00Z 2007 11     2008-04-11T19:55:24Z   0 0 09000064804296d6
FDA-2006-E-0383-0007 FDA Patent Extension Application for LEVEMIR insulin detemir (rDNA origin) injection, U.S. Patent No. 5,750,497 FDA-2006-E-0383 Notice of Final Determination from U.S. Patent and Trademark Office to Novo Nordisk, A/S Other Letter(s) 2007-11-19T05:00:00Z 2007 11     2025-12-19T21:52:23Z   0 0 09000064804603ab
FDA-2007-P-0352-0002 FDA FDA-2007-P-0352 FDA/CDER Interim Response to Sheppard, Mullin, Richter & Hampton, LLP - Letter Other LET-Letter 2007-11-19T05:00:00Z 2007 11     2013-07-27T20:40:29Z   0 0 090000648042b9da
FDA-2006-E-0261-0006 FDA Patent Extension Application for BARACLUDE (entecavir), U.S. Patent No. 5,206,244 FDA-2006-E-0261 USPTO to Bristol-Myers Squibb Company - Notice of Final Determination Other LET-Letter 2007-11-19T05:00:00Z 2007 11     2008-05-28T16:43:42Z   0 0 0900006480457a3a
FDA-2007-P-0246-0002 FDA FDA-2007-P-0246 FDA/CDER tp Sandoz, Inc. Other LET-Letter 2007-11-19T05:00:00Z 2007 11     2008-04-04T00:37:46Z   0 0 090000648042b100
FDA-2007-P-0301-0003 FDA FDA-2007-P-0301 Letter from FDA CFSAN to Barbara O. Schneeman Other Letter(s) 2007-11-16T05:00:00Z 2007 11     2025-03-13T16:02:17Z   0 0 090000648042b62b
FDA-2007-N-0035-0002 FDA FDA-2007-N-0035 Number not used Other ACK-Acknowledgement Letter 2007-11-15T05:00:00Z 2007 11     2008-04-04T00:35:32Z   0 0 09000064804295b6
FDA-2007-V-0021-0001 FDA FDA-2007-V-0021 Acknowledgement Letter to Mountain Megabytes Inc. Other ACK-Acknowledgement Letter 2007-11-15T05:00:00Z 2007 11     2008-04-10T10:55:28Z   0 0 0900006480429425
FDA-2000-N-0190-0017 FDA Egg Safety Action Plan FDA-2000-N-0190 Renee J. Wheeler Other MM-Memorandum of Meeting 2007-11-15T05:00:00Z 2007 11     2008-04-25T01:18:09Z   0 0 09000064804d4090
FDA-2005-D-0227-0016 FDA Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004; Guidance (Edition 2) FDA-2005-D-0227 FDA/CFSAN Response to Patricia Faison (Kellen Company) - Answer Other Answer 2007-11-14T05:00:00Z 2007 11     2012-03-14T00:35:26Z   0 0 09000064804420a0
FDA-2005-D-0227-0015 FDA Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004; Guidance (Edition 2) FDA-2005-D-0227 FDA/CFSAN Response to Jesper Korning (AAK) - Answer Other Answer 2007-11-14T05:00:00Z 2007 11     2012-03-14T00:27:33Z   0 0 090000648044209e
FDA-2007-P-0418-0001 FDA FDA-2007-P-0418 FDA/DDM to Cobalt Laboratories Inc. and Cobalt Pharmaceuticals Inc. Other ACK-Acknowledgement Letter 2007-11-13T05:00:00Z 2007 11     2008-04-04T00:38:17Z   0 0 090000648042da5d

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);